A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer
Pre-publication versions of this article are available by contacting email@example.com.
|28 Jan 2009||Submitted||Original manuscript|
|2 Mar 2009||Reviewed||Reviewer Report - Pierre Laurent-Puig|
|12 Mar 2009||Reviewed||Reviewer Report - Igor Jurisica|
|2 Apr 2009||Author responded||Author comments - Esther Black|
|Resubmission - Version 2|
|2 Apr 2009||Submitted||Manuscript version 2|
|26 Apr 2009||Reviewed||Reviewer Report - Pierre Laurent-Puig|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|13 May 2009||Editorially accepted|
|13 May 2009||Article published||10.1186/1471-2407-9-145|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.